BIO:VIR
Vir Biotechnology
- Stock
Last Close
6.95
22/11 21:00
Market Cap
1.14B
Beta: -
Volume Today
891.72K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
asset turnover | 0.00 - | 0.00 664.89% | 0.00 69.35% | 0.07 5,171.30% | 0.56 660.00% | 0.56 1.40% | 0.04 92.20% | |
cash conversion cycle | 241.09 - | 271.06 - | -16.02 105.91% | -54.94 242.92% | ||||
cash per share | 1.94 - | 1.02 47.61% | 12.63 1,143.74% | 6.18 51.05% | 5.45 11.83% | 18.11 232.24% | 11.45 36.79% | |
company equity multiplier | -3.65 - | -1.07 70.71% | 1.21 212.96% | 1.28 6.11% | 1.36 6.49% | 1.35 1.20% | 1.23 8.59% | |
days of inventory outstanding | 47.62 - | |||||||
days of payables outstanding | -241.09 - | 36.14 - | 16.02 55.67% | 104.07 549.59% | ||||
days of sales outstanding | 259.57 - | 49.13 - | ||||||
dividend yield | ||||||||
ebit per revenue | -546.96 - | -136.74 75.00% | -250.32 83.06% | -4.42 98.24% | 0.25 105.77% | 0.53 106.94% | -7.67 1,555.14% | |
ebt per ebit | 0.99 - | 0.98 1.09% | 0.98 0.02% | 1.01 2.54% | 1.99 97.48% | 0.91 54.40% | 0.95 4.96% | |
effective tax rate | 0.14 - | 0.00 96.95% | -0.00 121.39% | -0.00 79.51% | 0.04 21,440.77% | 0.32 719.13% | 0.02 93.41% | |
enterprise value multiple | -14.44 - | -11.31 21.70% | -1.53 86.45% | -9.50 519.96% | 18.48 294.53% | 2.79 84.89% | -1.90 168.07% | |
fixed asset turnover | 0.03 - | 0.07 143.54% | 0.04 38.27% | 0.84 1,830.56% | 8.36 893.07% | 8.40 0.49% | 0.52 93.86% | |
free cash flow per share | -0.71 - | -1.06 47.98% | -4.57 332.59% | -1.66 63.70% | -0.53 67.76% | 12.03 2,351.22% | -5.97 149.60% | |
gross profit margin | 1 - | 12.29 1,129.03% | 1 91.86% | 1 0% | 0.94 6.06% | 0.91 3.41% | 0.74 18.21% | |
interest coverage | 4.55 - | |||||||
inventory turnover | 7.66 - | |||||||
long term debt to capitalization | 1.31 - | 2.37 81.18% | 0.08 - | 0.09 0.43% | 0.06 34.08% | 0.07 16.66% | ||
net income per ebt | 0.86 - | 1.00 15.16% | 1.00 0.50% | 1.00 0.07% | 0.96 3.88% | 0.68 28.87% | 0.98 43.17% | |
net profit margin | -468.81 - | -133.51 71.52% | -245.69 84.03% | -4.44 98.19% | 0.49 110.95% | 0.33 32.88% | -7.14 2,286.68% | |
operating cash flow per share | -0.68 - | -0.97 41.75% | -4.27 339.91% | -1.60 62.48% | -0.37 77.13% | 12.54 3,523.30% | -5.81 146.29% | |
operating cycle | 307.20 - | 49.13 - | ||||||
operating profit margin | -546.96 - | -136.74 75.00% | -250.32 83.06% | -4.42 98.24% | 0.25 105.77% | 0.53 106.94% | -7.67 1,555.14% | |
payables turnover | -1.51 - | 10.10 - | 22.78 125.57% | 3.51 84.61% | ||||
pretax profit margin | -542.12 - | -134.06 75.27% | -245.47 83.10% | -4.44 98.19% | 0.51 111.39% | 0.48 5.64% | -7.29 1,627.36% | |
price fair value | -19.72 - | -7.58 61.54% | 0.90 111.88% | 4.45 394.29% | 3.80 14.68% | 1.62 57.47% | 0.85 47.47% | |
receivables turnover | 1.41 - | 7.43 - | ||||||
return on assets | -0.28 - | -0.60 117.83% | -0.34 43.60% | -0.33 4.71% | 0.27 183.20% | 0.18 31.94% | -0.31 270.46% | |
return on capital employed | -0.34 - | -0.78 129.59% | -0.39 49.77% | -0.36 7.81% | 0.17 147.38% | 0.36 111.82% | -0.37 201.86% | |
return on equity | 1.01 - | 0.65 36.19% | -0.41 163.71% | -0.42 1.11% | 0.37 188.61% | 0.25 32.76% | -0.39 255.81% | |
total debt to capitalization | 1.31 - | 2.23 70.73% | 0.00 99.97% | 0.09 15,914.67% | 0.09 2.09% | 0.06 33.78% | 0.07 25.19% |
All numbers in (except ratios and percentages)